Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS

Journal of Proteome Research

Volumn 12, Issue 2, 2013, Pages 679-691

  Hsu, Ping Ching ^a   Zhou, Bin ^b   Zhao, Yi ^b   Ressom, Habtom W ^b   Cheema, Amrita K ^b   Pickworth, Wallace ^c   Shields, Peter G ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

carcinogens; metabolism; metabolomics; nicotine; validation

Indexed keywords

CIGARETTE SMOKE; CREATININE; CYTOCHROME P450 2A6; CYTOCHROME P450 3A4;

ARTICLE; CANCER RISK; CARCINOGENESIS; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; LUNG CANCER; MEASUREMENT ERROR; METABOLOME; METABOLOMICS; MULTIDIMENSIONAL SCALING; PHENOTYPE; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUADRUPOLE WITH TIME OF FLIGHT MASS SPECTROMETRY; SMOKING; TIME OF FLIGHT MASS SPECTROMETRY; TOBACCO; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY EXCRETION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; HUMANS; METABOLOME; NICOTINE; OBSERVER VARIATION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SMOKING; TANDEM MASS SPECTROMETRY; TOBACCO; TOBACCO PRODUCTS;

EID: 84873326924     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3007705     Document Type: Article

References (73)

1. Department of Health U. S. Smoking and health. In The Surgeon General's Report on Nutrition and Health; United States. Public Health Service. Office of the Surgeon General: Washington, D.C., 1988; pp 5-11.
2. International Agency for Research on Cancer IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; IARC: Lyon, France, 2004; pp 53-119.
3. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking, Vol. 38; IARC: Lyon, 1986.
4. Institute of Medicine; Committee to Assess the Science Base for Tobacco Harm Reduction; Board on Health Promotion and Disease Prevention Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction; National Acadamy Press: Washington, D.C., 2001.
5. Institute of Medicine; Committee to Assess the Science Base for Tobacco Harm Reduction; Board on Population Health and Public Health Practice. Scientific Standards for Studies on Modified Risk Tobacco Products. 2011. Ref Type: Report
6. Centers for Disease Control and Prevention (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General; Atlanta, GA, 2010.
7. Wan, J.; Johnson, M.; Schilz, J.; Djordjevic, M. V.; Rice, J. R.; Shields, P. G. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco Cancer Epidemiol., Biomarkers Prev. 2009, 18, 3263-3304
8. Hatsukami, D. K.; Benowitz, N. L.; Rennard, S. I.; Oncken, C.; Hecht, S. S. Biomarkers to assess the utility of potential reduced exposure tobacco products Nicotine Tob. Res. 2006, 8, 600-622
9. Hoffmann, D.; Hoffmann, I.; El Bayoumy, K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder Chem. Res. Toxicol. 2001, 14, 767-790
10. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; IARC: Lyon, France, 2004.
11. Smith, C. J.; Perfetti, T. A.; Garg, R.; Hansch, C. IARC carcinogens reported in cigarette mainstream smoke and their calculated log P values Food Chem. Toxicol. 2003, 41, 807-817
12. Hecht, S. S. Tobacco smoke carcinogens and lung cancer J. Natl. Cancer Inst. 1999, 91, 1194-1210
13. Hecht, S. S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer Nat. Rev. Cancer 2003, 3, 733-744
14. Wright, W. E. Epidemiology of occupations. In Environmental and Occupational Medicine; Rom, W. N., Ed.; Little, Brown and Co.: Boston, 1983; pp 27-33.
15. Fowles, J.; Dybing, E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke Tob. Control 2003, 12, 424-430
16. International Agency for Research on Cancer IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; International Agency on the Research of Cancer: Lyon, France, 1982; pp 93-148.
17. Chen, C.; Gonzalez, F. J.; Idle, J. R. LC-MS-based metabolomics in drug metabolism Drug Metab. Rev. 2007, 39, 581-597
18. Idle, J. R.; Gonzalez, F. J. Metabolomics Cell Metab. 2007, 6, 348-351
19. Kaddurah-Daouk, R.; Kristal, B. S.; Weinshilboum, R. M. Metabolomics: a global biochemical approach to drug response and disease Annu. Rev. Pharmacol. Toxicol. 2008, 48, 653-683
20. Bain, J. R.; Stevens, R. D.; Wenner, B. R.; Ilkayeva, O.; Muoio, D. M.; Newgard, C. B. Metabolomics applied to diabetes research: moving from information to knowledge Diabetes 2009, 58, 2429-2443
21. Griffin, J. L. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2006, 361, 147-161
22. Lewis, G. D.; Asnani, A.; Gerszten, R. E. Application of metabolomics to cardiovascular biomarker and pathway discovery J. Am. Coll. Cardiol. 2008, 52, 117-123
23. Fernie, A. R.; Trethewey, R. N.; Krotzky, A. J.; Willmitzer, L. Metabolite profiling: from diagnostics to systems biology Nat. Rev. Mol. Cell Biol. 2004, 5, 763-769
24. Nicholson, J. K.; Wilson, I. D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism Nat. Rev. Drug Discov. 2003, 2, 668-676
25. Griffin, J. L. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2006, 361, 147-161
26. Weckwerth, W. Metabolomics: methods and protocols; Springer-Verlag: New York, 2006.
27. Kanani, H.; Chrysanthopoulos, P. K.; Klapa, M. I. Standardizing GC-MS metabolomics J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 871, 191-201
28. Kaddurah-Daouk, R.; Boyle, S.; Matson, W.; Sharma, S.; Matson, S.; Zhu, H.; Bogdanov, M.; Churchill, E.; Krishnan, R.; Rush, A.; Pickering, E.; Delnomdedieu, M. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Transl. Psychiatry 2011, 1.
29. O'Grady, J.; Schwender, J.; Shachar-Hill, Y.; Morgan, J. A. Metabolic cartography: experimental quantification of metabolic fluxes from isotopic labelling studies J. Exp. Bot. 2012, 63, 2293-2308
30. Reo, N. V. NMR-based metabolomics Drug Chem. Toxicol. 2002, 25, 375-382
31. Zhou, B.; Xiao, J. F.; Tuli, L.; Ressom, H. W. LC-MS-based metabolomics Mol. Biosyst. 2012, 8, 470-481
32. Psychogios, N.; Hau, D. D.; Peng, J.; Guo, A. C.; Mandal, R.; Bouatra, S.; Sinelnikov, I.; Krishnamurthy, R.; Eisner, R.; Gautam, B.; Young, N.; Xia, J.; Knox, C.; Dong, E.; Huang, P.; Hollander, Z.; Pedersen, T. L.; Smith, S. R.; Bamforth, F.; Greiner, R.; McManus, B.; Newman, J. W.; Goodfriend, T.; Wishart, D. S. The human serum metabolome PLoS One 2011, 6, e16957
33. Bathe, O. F.; Shaykhutdinov, R.; Kopciuk, K.; Weljie, A. M.; McKay, A.; Sutherland, F. R.; Dixon, E.; Dunse, N.; Sotiropoulos, D.; Vogel, H. J. Feasibility of identifying pancreatic cancer based on serum metabolomics Cancer Epidemiol. Biomarkers Prev. 2011, 20, 140-147
34. Ciborowski, M.; Javier, R. F.; Martinez-Alcazar, M. P.; Angulo, S.; Radziwon, P.; Olszanski, R.; Kloczko, J.; Barbas, C. Metabolomic approach with LC-MS reveals significant effect of pressure on diver's plasma J. Proteome Res. 2010, 9, 4131-4137
35. Sato, Y.; Suzuki, I.; Nakamura, T.; Bernier, F.; Aoshima, K.; Oda, Y. Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology J. Lipid Res. 2012, 53, 567-576
36. Gika, H. G.; Macpherson, E.; Theodoridis, G. A.; Wilson, I. D. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2008, 871, 299-305
37. Guy, P. A.; Tavazzi, I.; Bruce, S. J.; Ramadan, Z.; Kochhar, S. Global metabolic profiling analysis on human urine by UPLC-TOFMS: issues and method validation in nutritional metabolomics J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2008, 871, 253-260
38. Want, E. J.; Wilson, I. D.; Gika, H.; Theodoridis, G.; Plumb, R. S.; Shockcor, J.; Holmes, E.; Nicholson, J. K. Global metabolic profiling procedures for urine using UPLC-MS Nat. Protoc. 2010, 5, 1005-1018
39. Gika, H. G.; Theodoridis, G. A.; Wingate, J. E.; Wilson, I. D. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine J. Proteome Res. 2007, 6, 3291-3303
40. Crews, B.; Wikoff, W. R.; Patti, G. J.; Woo, H. K.; Kalisiak, E.; Heideker, J.; Siuzdak, G. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data Anal. Chem. 2009, 81, 8538-8544
41. Smith, C. A.; Want, E. J.; O'Maille, G.; Abagyan, R.; Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification Anal. Chem. 2006, 78, 779-787
42. Xia, J.; Psychogios, N.; Young, N.; Wishart, D. S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation Nucleic Acids Res. 2009, 37, W652-W660
43. Cui, Q.; Lewis, I. A.; Hegeman, A. D.; Anderson, M. E.; Li, J.; Schulte, C. F.; Westler, W. M.; Eghbalnia, H. R.; Sussman, M. R.; Markley, J. L. Metabolite identification via the Madison Metabolomics Consortium Database Nat. Biotechnol. 2008, 26, 162-164
44. Wishart, D. S. Human Metabolome Database: completing the 'human parts list' Pharmacogenomics 2007, 8, 683-686
45. Wedge, D. C.; Allwood, J. W.; Dunn, W.; Vaughan, A. A.; Simpson, K.; Brown, M.; Priest, L.; Blackhall, F. H.; Whetton, A. D.; Dive, C.; Goodacre, R. Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer Anal. Chem. 2011, 83, 6689-6697
46. Yu, Z.; Kastenmuller, G.; He, Y.; Belcredi, P.; Moller, G.; Prehn, C.; Mendes, J.; Wahl, S.; Roemisch-Margl, W.; Ceglarek, U.; Polonikov, A.; Dahmen, N.; Prokisch, H.; Xie, L.; Li, Y.; Wichmann, H. E.; Peters, A.; Kronenberg, F.; Suhre, K.; Adamski, J.; Illig, T.; Wang-Sattler, R. Differences between human plasma and serum metabolite profiles PLoS One 2011, 6, e21230
47. Hatsukami, D. K.; Slade, J.; Benowitz, N. L.; Giovino, G. A.; Gritz, E. R.; Leischow, S.; Warner, K. E. Reducing tobacco harm: research challenges and issues Nicotine Tob. Res. 2002, 4, S89-S101
48. Oberg, A. L.; Vitek, O. Statistical design of quantitative mass spectrometry-based proteomic experiments J. Proteome Res. 2009, 8, 2144-2156
49. Smilde, A. K.; van der Werf, M. J.; Schaller, J. P.; Kistemaker, C. Characterizing the precision of mass-spectrometry-based metabolic profiling platforms Analyst 2009, 134, 2281-2285
50. Dettmer, K.; Aronov, P. A.; Hammock, B. D. Mass spectrometry-based metabolomics Mass Spectrom. Rev. 2007, 26, 51-78
51. Jameson, D.; Verma, M.; Westerhoff, H. V. Methods in Systems Biology; Academic Press: New York, 2012; Vol. 500, p 21.
52. Lange, E.; Tautenhahn, R.; Neumann, S.; Gropl, C. Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements BMC Bioinform. 2008, 9, 375
53. Zelena, E.; Dunn, W. B.; Broadhurst, D.; Francis-McIntyre, S.; Carroll, K. M.; Begley, P.; O'Hagan, S.; Knowles, J. D.; Halsall, A.; Wilson, I. D.; Kell, D. B. Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum Anal. Chem. 2009, 81, 1357-1364
54. Denery, J. R.; Nunes, A. A.; Dickerson, T. J. Characterization of differences between blood sample matrices in untargeted metabolomics Anal. Chem. 2011, 83, 1040-1047
55. Ahijevych, K.; Gillespie, J.; Demirci, M.; Jagadeesh, J. Menthol and nonmenthol cigarettes and smoke exposure in black and white women Pharmacol., Biochem. Behav. 1996, 53, 355-360
56. Assaf, A. R.; Parker, D.; Lapane, K. L.; McKenney, J. L.; Carleton, R. A. Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program J. Womens Health 2002, 11, 899-906
57. Lombardo, T.; Carreno, L. Relationship of type A behavior pattern in smokers to carbon monoxide exposure and smoking topography Health Psychol. 1987, 6, 445-452
58. Lerman, C.; Berrettini, W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2003, 118B, 48-54
59. Benowitz, N. L. Nicotine addiction Prim. Care 1999, 26, 611-631
60. Messina, E. S.; Tyndale, R. F.; Sellers, E. M. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes J. Pharmacol. Exp. Ther. 1997, 282, 1608-1614
61. Nakajima, M.; Yamamoto, T.; Nunoya, K.; Yokoi, T.; Nagashima, K.; Inoue, K.; Funae, Y.; Shimada, N.; Kamataki, T.; Kuroiwa, Y. Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes J. Pharmacol. Exp. Ther. 1996, 277, 1010-1015
62. Dempsey, D.; Tutka, P.; Jacob, P., III; Allen, F.; Schoedel, K.; Tyndale, R. F.; Benowitz, N. L. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity Clin. Pharmacol. Ther. 2004, 76, 64-72
63. Hecht, S. S.; Hochalter, J. B.; Villalta, P. W.; Murphy, S. E. 2′-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 12493-12497
64. Wada, E. Y. K. Degradation of Nicotine by Soil Bacteria J. Am. Chem. Soc. 1954, 76, 155-157
65. Caldwell, W. S.; Greene, J. M.; Dobson, G. P.; deBethizy, J. D. Intragastric nitrosation of nicotine is not a significant contributor to nitrosamine exposure Ann. N.Y. Acad. Sci. 1993, 686, 213-227
66. Holmes, E.; Li, J. V.; Athanasiou, T.; Ashrafian, H.; Nicholson, J. K. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease Trends Microbiol. 2011, 19, 349-359
67. Wikoff, W. R.; Anfora, A. T.; Liu, J.; Schultz, P. G.; Lesley, S. A.; Peters, E. C.; Siuzdak, G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 3698-3703
68. Lewis, D. F.; Ito, Y.; Lake, B. G. Metabolism of coumarin by human P450s: a molecular modelling study Toxicol. In Vitro 2006, 20, 256-264
69. Strasser, A. A.; Lerman, C.; Sanborn, P. M.; Pickworth, W. B.; Feldman, E. A. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure Drug Alcohol Depend. 2007, 86, 294-300
70. Ceglarek, U.; Leichtle, A.; Brugel, M.; Kortz, L.; Brauer, R.; Bresler, K.; Thiery, J.; Fiedler, G. M. Challenges and developments in tandem mass spectrometry based clinical metabolomics Mol. Cell. Endocrinol. 2009, 301, 266-271
71. Serkova, N. J.; Glunde, K. Metabolomics of cancer Methods Mol. Biol. 2009, 520, 273-295
72. Spratlin, J. L.; Serkova, N. J.; Eckhardt, S. G. Clinical applications of metabolomics in oncology: a review Clin. Cancer Res. 2009, 15, 431-440
73. Hatsukami, D. K.; Benowitz, N. L.; Rennard, S. I.; Oncken, C.; Hecht, S. S. Biomarkers to assess the utility of potential reduced exposure tobacco products Nicotine Tob. Res. 2006, 8, 169-191